101.99
-11.22%
Close of 20 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
Price performance
Chart by TradingView, with its own licensed prices
- Market value
- $3.74bn
- Last close × shares
- Volume
- 852k
- Shares, 20 Nov 2026
- Price to earnings
- 99.0
About Novanta
From its filings with the US Securities and Exchange Commission
Novanta is based in Bedford, Massachusetts and is incorporated in New Brunswick, Canada. Its shares trade on Nasdaq under the ticker NOVT. The SEC classifies its business as miscellaneous electrical machinery, equipment & supplies. In the fiscal year to 31 December 2025, it reported revenue of $980.6m and net income of $53.8m. At that date it held total assets of $1.81bn and shareholders' equity of $1.31bn. By business, Robotics and Automation brought in 32.5% of revenue, followed by Advanced Surgery at 24.7% and Precision Medicine at 24.2%. By region, UNITED STATES accounted for 52.9%, followed by Rest Of Europe at 14.0% and GERMANY at 11.7%.
Novanta Inc. and its subsidiaries (collectively referred to as the “Company”, “Novanta”, “we”, “us”, “our”) is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers (“OEMs”) a competitive advantage. We combine deep proprietary technology expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability to solve complex technical challenges. This enables us to engineer proprietary technology solutions that deliver extreme precision and performance, tailored to our customers' demanding applications.
The Company was founded and initially incorporated in Massachusetts in 1968 as General Scanning, Inc. (“General Scanning”). In 1999, General Scanning merged with Lumonics Inc. The post-merger entity, GSI Lumonics Inc., continued under the laws of the Province of New Brunswick, Canada. In 2005, the Company changed its name to GSI Group Inc. Through a series of strategic divestitures and acquisitions, the Company transformed from one that was more focused on the semiconductor industry to one that primarily develops and supplies components and sub-systems to OEMs in the medical and advanced industrial markets. The Company changed its name to Novanta Inc. in May 2016.
Quoted from its 10-K, filed 23 Feb 2026. Read the filing on SEC.gov ↗
How it makes its money
Revenue, year to 31 Dec 2025
- Robotics and Automation $318.6m · 32.5%
- Advanced Surgery $242.4m · 24.7%
- Precision Medicine $237.3m · 24.2%
- Precision Manufacturing [Member] $182.3m · 18.6%
Latest on Novanta
Our reporting
Next results
Due on 22 Feb 2027. Analysts expect earnings of 0.92 a share.
Other Information Technology listings
Scenario calculator
Try your own numbers. This is arithmetic, not a forecast.
Gain or loss
Return
Leaves out fees, taxes and financing.
Frequently asked questions
What is Novanta's ticker?
Novanta trades as NOVT on its US listing, under ISIN CA67000B1040.
What was Novanta's last closing price?
101.99 on 20 Nov 2026. The figure is in USD and is never converted.
When does Novanta next report results?
Results are expected on 9 Nov 2026, according to our data supplier.
Sources and methodology
- Chart
- TradingView
- Close and company data
- SEC filings and our data supplier
- News
- Our reporting
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.